Form 4 for TNDM TANDEM DIABETES CARE INC
Accepted 2025-02-27 00:00:00 ET · period of report 2025-02-25 · accession 0001438133-25-000038 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-27 | 2025-02-25 | TNDM | Gasser Elizabeth Anne | EVP, Chief Strategy Off | F - Tax | $33.34 | -3,748 | 4,509 | -45% | -$125.0K |
| DM | 2025-02-27 | 2025-02-25 | TNDM | Gasser Elizabeth Anne | EVP, Chief Strategy Off | M - OptEx | $0.00 | +6,903 | 5,248 | New | $0 |
| DM | 2025-02-27 | 2025-02-25 | TNDM | Gasser Elizabeth Anne | EVP, Chief Strategy Off | M - OptEx | $0.00 | -6,903 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-25 | F | D | 3,009 | $33.34 | 7,023 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-25 | M | A | 5,523 | $0.00 | 10,032 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-25 | F | D | 739 | $33.34 | 4,509 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-25 | M | A | 1,380 | $0.00 | 5,248 | D | — | — | |
| 5 | Derivative | Performance Stock Unit | 2025-02-25 | M | D | 1,380 | $0.00 | 0 | D | — · — to — | 1,380 Common Stock | (F3) Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). (F4) Each PSU represents a contingent right to receive one share of the Company common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the Measurement Date). The number of shares issued may range from 0% to 200% of the base grant amount, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSUs will vest. |
| 6 | Derivative | Performance Stock Unit | 2025-02-25 | M | D | 5,523 | $0.00 | 0 | D | — · — to — | 5,523 Common Stock | (F5) Awarded on May 25, 2022 pursuant to the 2013 Plan. (F4) Each PSU represents a contingent right to receive one share of the Company common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the Measurement Date). The number of shares issued may range from 0% to 200% of the base grant amount, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSUs will vest. |